Key result
Medetomidine/midazolam/fentanyl (MMF) narcosis led to significant bradycardia, spontaneous arrhythmias, and sinus and AV node dysfunction compared to isoflurane/fentanyl (IF) narcosis and awake mice.
Why the study?
Despite evidence of adverse effects of individual anesthetic components on cardiac function, few data are available regarding the specific effects of commonly used MMF and IF narcosis regimens on cardiac electrophysiology in mice.
Does medetomidine/midazolam/fentanyl (MMF) narcosis alter cardiac electrophysiology and increase arrhythmia susceptibility compared to isoflurane/fentanyl (IF) or awake state in C57BL/6N wild-type mice?
Does medetomidine/midazolam/fentanyl (MMF) narcosis alter cardiac electrophysiology and increase arrhythmia susceptibility compared to isoflurane/fentanyl (IF) or awake state in C57BL/6N wild-type mice?
Medetomidine/midazolam/fentanyl (MMF) narcosis profoundly alters cardiac electrophysiology and induces arrhythmias in mice, suggesting isoflurane/fentanyl should be preferred for preclinical arrhythmia research.
MMF anesthesia was associated with bradycardia and spontaneous arrhythmias in mice; leaves open optimal anesthetic choice for translational arrhythmia models.
Arrhythmias are critical contributors to cardiovascular morbidity and mortality. Therapies are mainly symptomatic and often insufficient, emphasizing the need for basic research to unveil the mechanisms underlying arrhythmias and to enable better and ideally causal therapies. In translational approaches, mice are commonly used to study arrhythmia mechanisms in vivo. Experimental electrophysiology studies in mice are performed under anesthesia with medetomidine/midazolam/fentanyl (MMF) and isoflurane/fentanyl (IF) as commonly used regimens. Despite evidence of adverse effects of individual components on cardiac function, few data are available regarding the specific effects of these regimens on cardiac electrophysiology in mice. Here we present a study investigating the effects of MMF and IF narcosis on cardiac electrophysiology in vivo in C57BL/6N wild-type mice. Telemetry transmitters were implanted in a group of mice, which served as controls for baseline parameters without narcosis. In two other groups of mice, electrocardiogram and invasive electrophysiology studies were performed under narcosis (with either MMF or IF). Basic electrocardiogram parameters, heart rate variability parameters, sinus node and atrioventricular node function, and susceptibility to arrhythmias were assessed. Experimental data suggest a remarkable influence of MMF on cardiac electrophysiology compared with IF and awake animals. While IF only moderately reduced heart rate, MMF led to significant bradycardia, spontaneous arrhythmias, heart rate variability alterations as well as sinus and AV node dysfunction, and increased inducibility of ventricular arrhythmias. On the basis of these observed effects, we suggest avoiding MMF in mice, specifically when studying cardiac electrophysiology, but also whenever a regular heartbeat is required for reliable results, such as in heart failure or imaging research.
No takes yet. Share an insight, caveat, or question.
Tomsits et al. (2023) studied Healthy wild-type mice (n=29). Medetomidine/midazolam/fentanyl (MMF) narcosis vs. Isoflurane/fentanyl (IF) narcosis and awake controls was evaluated on Heart rate (p=<0.0001). Medetomidine/midazolam/fentanyl (MMF) narcosis led to significant bradycardia, spontaneous arrhythmias, and sinus and AV node dysfunction compared to isoflurane/fentanyl (IF) narcosis and awake mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: